ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 96 filers reported holding ENDOCYTE INC in Q4 2016. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $38,000 | -83.6% | 27,156 | -82.5% | 0.00% | -83.3% |
| Q2 2017 | $232,000 | +125.2% | 155,131 | +286.7% | 0.01% | +140.0% |
| Q1 2017 | $103,000 | +60.9% | 40,120 | +59.8% | 0.01% | +25.0% |
| Q4 2016 | $64,000 | -34.0% | 25,100 | -17.1% | 0.00% | -20.0% |
| Q2 2016 | $97,000 | -66.7% | 30,273 | -67.8% | 0.01% | -61.5% |
| Q1 2016 | $291,000 | -12.6% | 93,973 | +13.1% | 0.01% | -18.8% |
| Q4 2015 | $333,000 | +99.4% | 83,073 | +127.2% | 0.02% | +166.7% |
| Q3 2015 | $167,000 | +16.8% | 36,571 | +32.2% | 0.01% | +20.0% |
| Q2 2015 | $143,000 | -27.0% | 27,658 | -11.8% | 0.01% | -28.6% |
| Q1 2015 | $196,000 | -89.6% | 31,358 | -89.9% | 0.01% | -92.0% |
| Q3 2014 | $1,892,000 | -6.2% | 311,217 | +1.7% | 0.09% | -17.1% |
| Q2 2014 | $2,016,000 | +298.4% | 305,975 | +1337.0% | 0.10% | +288.9% |
| Q1 2014 | $506,000 | +25.6% | 21,292 | -43.6% | 0.03% | +28.6% |
| Q4 2013 | $403,000 | -33.1% | 37,764 | -16.5% | 0.02% | -36.4% |
| Q3 2013 | $602,000 | +25.9% | 45,221 | +24.0% | 0.03% | +106.2% |
| Q2 2013 | $478,000 | – | 36,470 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|